Ascendis Pharma A/S (NASDAQ:ASND – Get Free Report) had its price objective hoisted by research analysts at JPMorgan Chase & Co. from $167.00 to $168.00 in a report released on Thursday,Benzinga ...

D. Boral Capital reaffirmed their buy rating on shares of Anavex Life Sciences (NASDAQ:AVXL – Free Report) in a report published on Wednesday morning,Benzinga reports. D. Boral Capital currently has a ...

Brent Sabatini, the Senior Vice President and Chief Accounting Officer at Vir Biotechnology, Inc. (NASDAQ:VIR), recently sold 1,562 shares of the company's common stock. According to InvestingPro data ...

Speaking this week at BIO CEO, the heads of Septerna, Upstream Bio and Actuate Therapeutics shared lessons from going public ...

Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily ...

Operator: Thank you for standing by, and welcome to the Origin Agritech Fiscal Year 2024 Conference Call. Please note that, today ...

Yale researchers have created "Ochre," a genomically recoded organism that enables the production of synthetic proteins with ...

Virginia Tech is leading the effort that aims to strengthen bonds between biomedical companies and sector leaders.

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Darwin's theory of natural selection provides an explanation for why organisms develop traits that help them survive and reproduce. Because of this, death is often seen as a failure rather than a ...

Researchers have successfully uncovered the molecular mechanisms by which bacterial cellulose patches stimulate the regeneration of plant wounds.   - The regeneration process requires the activation ...

Gabe Gelman, head of Americas equity capital markets at Goldman Sachs Group Inc., is leaving the firm after more than 25 ...